537 related articles for article (PubMed ID: 22245332)
1. Early detection of carcinoma in situ of the bladder: a comparative study of white light cystoscopy, narrow band imaging, 5-ALA fluorescence cystoscopy and 3-dimensional optical coherence tomography.
Ren H; Park KC; Pan R; Waltzer WC; Shroyer KR; Pan Y
J Urol; 2012 Mar; 187(3):1063-70. PubMed ID: 22245332
[TBL] [Abstract][Full Text] [Related]
2. Enhancing detection of bladder carcinoma in situ by 3-dimensional optical coherence tomography.
Ren H; Yuan Z; Waltzer W; Shroyer K; Pan Y
J Urol; 2010 Oct; 184(4):1499-506. PubMed ID: 20723922
[TBL] [Abstract][Full Text] [Related]
3. New optical imaging technologies for bladder cancer: considerations and perspectives.
Liu JJ; Droller MJ; Liao JC
J Urol; 2012 Aug; 188(2):361-8. PubMed ID: 22698620
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence guided optical coherence tomography for the diagnosis of early bladder cancer in a rat model.
Wang ZG; Durand DB; Schoenberg M; Pan YT
J Urol; 2005 Dec; 174(6):2376-81. PubMed ID: 16280851
[TBL] [Abstract][Full Text] [Related]
5. Visualization of the basement membrane zone of the bladder by optical coherence tomography: feasibility of noninvasive evaluation of tumor invasion.
Hermes B; Spöler F; Naami A; Bornemann J; Först M; Grosse J; Jakse G; Knüchel R
Urology; 2008 Sep; 72(3):677-81. PubMed ID: 18455778
[TBL] [Abstract][Full Text] [Related]
6. High magnification cystoscopy in the primary diagnosis of bladder tumors.
Jichlinski P; Lovisa B
Curr Opin Urol; 2011 Sep; 21(5):398-402. PubMed ID: 21730856
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence cystoscopy with high-resolution optical coherence tomography imaging as an adjunct reduces false-positive findings in the diagnosis of urothelial carcinoma of the bladder.
Schmidbauer J; Remzi M; Klatte T; Waldert M; Mauermann J; Susani M; Marberger M
Eur Urol; 2009 Dec; 56(6):914-9. PubMed ID: 19674831
[TBL] [Abstract][Full Text] [Related]
8. Novel endoscopic diagnosis for bladder cancer.
Lerner SP; Goh A
Cancer; 2015 Jan; 121(2):169-78. PubMed ID: 25132313
[TBL] [Abstract][Full Text] [Related]
9. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study.
Fradet Y; Grossman HB; Gomella L; Lerner S; Cookson M; Albala D; Droller MJ;
J Urol; 2007 Jul; 178(1):68-73; discussion 73. PubMed ID: 17499291
[TBL] [Abstract][Full Text] [Related]
10. The past, present and future of cystoscopy: the fusion of cystoscopy and novel imaging technology.
Lee CS; Yoon CY; Witjes JA
BJU Int; 2008 Nov; 102(9 Pt B):1228-33. PubMed ID: 19035886
[TBL] [Abstract][Full Text] [Related]
11. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study.
Jocham D; Witjes F; Wagner S; Zeylemaker B; van Moorselaar J; Grimm MO; Muschter R; Popken G; König F; Knüchel R; Kurth KH
J Urol; 2005 Sep; 174(3):862-6; discussion 866. PubMed ID: 16093971
[TBL] [Abstract][Full Text] [Related]
12. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer.
Grossman HB; Gomella L; Fradet Y; Morales A; Presti J; Ritenour C; Nseyo U; Droller MJ;
J Urol; 2007 Jul; 178(1):62-7. PubMed ID: 17499283
[TBL] [Abstract][Full Text] [Related]
13. Optical coherence tomography as an adjunct to white light cystoscopy for intravesical real-time imaging and staging of bladder cancer.
Goh AC; Tresser NJ; Shen SS; Lerner SP
Urology; 2008 Jul; 72(1):133-7. PubMed ID: 18598789
[TBL] [Abstract][Full Text] [Related]
14. Positive urine cytology but negative white-light cystoscopy: an indication for fluorescence cystoscopy?
Karl A; Tritschler S; Stanislaus P; Gratzke C; Tilki D; Strittmatter F; Knüchel R; Stief CG; Zaak D
BJU Int; 2009 Feb; 103(4):484-7. PubMed ID: 18793301
[TBL] [Abstract][Full Text] [Related]
15. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy.
Schmidbauer J; Witjes F; Schmeller N; Donat R; Susani M; Marberger M;
J Urol; 2004 Jan; 171(1):135-8. PubMed ID: 14665861
[TBL] [Abstract][Full Text] [Related]
16. New imaging techniques for nonmuscle invasive bladder cancer.
von Rundstedt FC; Lerner SP
Curr Opin Urol; 2014 Sep; 24(5):532-9. PubMed ID: 25051025
[TBL] [Abstract][Full Text] [Related]
17. Applying narrow-band imaging in complement with white-light imaging cystoscopy in the detection of urothelial carcinoma of the bladder.
Chen G; Wang B; Li H; Ma X; Shi T; Zhang X
Urol Oncol; 2013 May; 31(4):475-9. PubMed ID: 22079940
[TBL] [Abstract][Full Text] [Related]
18. The role of narrow-band imaging in the management of non-muscle-invasive bladder cancer.
Naselli A; Hurle R; Puppo P
Expert Rev Anticancer Ther; 2012 Dec; 12(12):1523-8. PubMed ID: 23253218
[TBL] [Abstract][Full Text] [Related]
19. A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences.
Herr HW; Donat SM
BJU Int; 2008 Nov; 102(9):1111-4. PubMed ID: 18778359
[TBL] [Abstract][Full Text] [Related]
20. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence.
Kriegmair M; Baumgartner R; Knüchel R; Stepp H; Hofstädter F; Hofstetter A
J Urol; 1996 Jan; 155(1):105-9; discussion 109-10. PubMed ID: 7490803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
